Daily Margin Trading Facility book for Suven Life Sciences across NSE and BSE, from 02 Aug 2017. All figures in ₹ crore, derived from exchange public disclosures.
What is Suven Life Sciences’s MTF book?
Suven Life Sciences Limited (SUVEN) has ₹64 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.04% of India’s MTF book, ranking #539. Over 1M (the last 30 trading days) the funded value has risen 1.1%, with the number of shares under margin down 3.2%.
Share of free float on margin, month by month
Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.
View as table: share of free float on margin10 months
| Month-end | % of free float |
|---|---|
| 23 Oct 2026 | 2.143% |
| 30 Sep 2026 | 2.198% |
| 31 Aug 2026 | 2.246% |
| 31 Jul 2026 | 2.613% |
| 30 Jun 2026 | 2.767% |
| 29 May 2026 | 1.863% |
| 30 Apr 2026 | 1.053% |
| 12 Jun 2025† | 0.953% |
| 30 May 2025 | 1.407% |
| 30 Apr 2025 | 1.010% |
† Not the month’s last trading day: the last day the stock was in the archive that month (before 11 Nov 2025 the archive kept only the 500 largest positions).
Dated events
- 02 Aug 2017First recorded in the MTF book
NSE & BSE split
MTF vs Price
Price and liquidity
Book, shares and price by window
| Window | Book Δ | Book % | Shares | Price | Reading |
|---|---|---|---|---|---|
| 1D | −₹0 | −0.8% | −0.8% −16,538 | −2.6% | unwinding as it falls |
| 10D | −₹3 | −4.9% | −5.5% −1,20,796 | −9.5% | unwinding as it falls |
| 1M | +₹1 | +1.1% | −3.2% −69,215 | −29.3% | unwinding as it falls |
| 3M | −₹3 | −5.1% | −13.4% −3,22,829 | −17.6% | unwinding as it falls |
| 6M | not enough history | ||||
| 1Y | not enough history | ||||
Shares under margin
Rank trajectory
SUVEN — last 30 trading days
| Date | Combined (₹ Cr) | Day Δ (₹ Cr) | % of book | Rank |
|---|---|---|---|---|
| 23 Oct 2026 | 64 | −₹0 | 0.04% | 539 |
| 22 Oct 2026 | 64 | −₹2 | 0.04% | 543 |
| 21 Oct 2026 | 66 | −₹1 | 0.04% | 542 |
| 19 Oct 2026 | 68 | +₹1 | 0.04% | 535 |
| 16 Oct 2026 | 67 | +₹0 | 0.04% | 541 |
| 15 Oct 2026 | 66 | +₹1 | 0.04% | 540 |
| 14 Oct 2026 | 66 | +₹0 | 0.04% | 541 |
| 13 Oct 2026 | 66 | −₹1 | 0.04% | 540 |
| 12 Oct 2026 | 66 | −₹0 | 0.04% | 533 |
| 09 Oct 2026 | 66 | −₹1 | 0.04% | 536 |
| 08 Oct 2026 | 67 | +₹0 | 0.04% | 537 |
| 07 Oct 2026 | 67 | +₹1 | 0.04% | 540 |
| 06 Oct 2026 | 66 | +₹1 | 0.04% | 540 |
| 05 Oct 2026 | 65 | +₹2 | 0.04% | 546 |
| 01 Oct 2026 | 64 | −₹2 | 0.04% | 555 |
| 30 Sep 2026 | 66 | +₹4 | 0.04% | 547 |
| 29 Sep 2026 | 61 | −₹1 | 0.04% | 571 |
| 28 Sep 2026 | 62 | +₹1 | 0.04% | 564 |
| 25 Sep 2026 | 61 | −₹5 | 0.04% | 569 |
| 24 Sep 2026 | 66 | −₹2 | 0.04% | 546 |
| 23 Sep 2026 | 68 | +₹0 | 0.04% | 534 |
| 22 Sep 2026 | 68 | +₹0 | 0.04% | 531 |
| 21 Sep 2026 | 68 | +₹1 | 0.04% | 532 |
| 18 Sep 2026 | 67 | +₹1 | 0.04% | 529 |
| 17 Sep 2026 | 66 | −₹1 | 0.04% | 538 |
| 16 Sep 2026 | 67 | +₹0 | 0.04% | 532 |
| 15 Sep 2026 | 67 | +₹1 | 0.04% | 538 |
| 11 Sep 2026 | 66 | +₹1 | 0.04% | 543 |
| 10 Sep 2026 | 65 | +₹0 | 0.04% | 554 |
| 09 Sep 2026 | 64 | — | 0.04% | 549 |
SUVEN within Health Technology
| # | Stock | MTF book (₹ Cr) | % of sector | % of free float | Book, 1M |
|---|---|---|---|---|---|
| 24 | GLANDGland Pharma | ₹72 | 1.1% | 0.30% | −65.4% |
| 25 | ANTHEMAnthem Biosciences | ₹67 | 1.0% | 0.47% | −3.3% |
| 26 | SUVENSuven Life Sciences | ₹64 | 1.0% | 2.14% | +1.1% |
| 27 | SUDEEPPHRMSudeep Pharma | ₹62 | 0.9% | 2.31% | +16.3% |
| 28 | MANKINDMankind Pharma | ₹58 | 0.9% | 0.21% | −41.3% |
